Therapeutic drug monitoring for sofosbuvir and daclatasvir in transplant recipients with chronic hepatitis C and advanced renal disease

Affiliations

¹ Transplantation Center, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland; Service of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland. Electronic address: Julien.Vionnet@chuv.ch.
² Transplantation Center, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.
³ Service of Nephrology, Hôpital de la Providence, Neuchâtel, Switzerland.
⁴ Laboratory of Clinical Pharmacology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.
⁵ Service of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.
⁶ Division of Clinical Pharmacology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.

Julien Vionnet et al. J Hepatol. 2016 Nov.

. 2016 Nov;65(5):1063-1065.

doi: 10.1016/j.jhep.2016.06.032. Epub 2016 Jul 25.

¹ Transplantation Center, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland; Service of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland. Electronic address: Julien.Vionnet@chuv.ch.
² Transplantation Center, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.
³ Service of Nephrology, Hôpital de la Providence, Neuchâtel, Switzerland.
⁴ Laboratory of Clinical Pharmacology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.
⁵ Service of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.
⁶ Division of Clinical Pharmacology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.

No abstract available

Comment in

Reply to: "Therapeutic drug monitoring for sofosbuvir and daclatasvir in transplant recipients with chronic hepatitis C and advanced renal disease".
Desnoyer A, Lê MP, Yazdanpanah Y, Peytavin G; co-authors. Desnoyer A, et al. J Hepatol. 2016 Nov;65(5):1065-1066. doi: 10.1016/j.jhep.2016.07.019. Epub 2016 Jul 25. J Hepatol. 2016. PMID: 27460834 No abstract available.